Your browser is no longer supported. Please, upgrade your browser.
Settings
CMRX Chimerix, Inc. daily Stock Chart
CMRX [NASD]
Chimerix, Inc.
Index- P/E- EPS (ttm)-1.32 Insider Own1.00% Shs Outstand62.24M Perf Week-12.50%
Market Cap152.49M Forward P/E- EPS next Y-1.17 Insider Trans14.33% Shs Float50.47M Perf Month-32.51%
Income-66.40M PEG- EPS next Q-0.22 Inst Own67.40% Short Float1.81% Perf Quarter-30.00%
Sales9.00M P/S16.94 EPS this Y5.40% Inst Trans5.33% Short Ratio2.36 Perf Half Y24.37%
Book/sh2.92 P/B0.84 EPS next Y-7.30% ROA-36.30% Target Price4.67 Perf Year-39.51%
Cash/sh2.54 P/C0.96 EPS next 5Y- ROE-39.00% 52W Range1.74 - 4.40 Perf YTD-4.67%
Dividend- P/FCF- EPS past 5Y17.10% ROI-40.50% 52W High-44.77% Beta1.37
Dividend %- Quick Ratio11.70 Sales past 5Y10.60% Gross Margin- 52W Low39.66% ATR0.20
Employees82 Current Ratio11.70 Sales Q/Q16.70% Oper. Margin- RSI (14)26.58 Volatility8.00% 7.05%
OptionableYes Debt/Eq0.00 EPS Q/Q11.30% Profit Margin- Rel Volume0.45 Prev Close2.45
ShortableYes LT Debt/Eq0.00 EarningsAug 14 BMO Payout- Avg Volume386.66K Price2.43
Recom3.00 SMA20-20.37% SMA50-29.08% SMA200-16.45% Volume41,788 Change-0.82%
Feb-14-18Downgrade JP Morgan Neutral → Underweight
Feb-02-18Initiated H.C. Wainwright Buy $10
Aug-09-16Reiterated FBR Capital Mkt Perform $9 → $8
Feb-23-16Reiterated FBR Capital Mkt Perform $14 → $10
Feb-23-16Downgrade Morgan Stanley Equal-Weight → Underweight
Feb-23-16Downgrade Barclays Overweight → Equal Weight $12 → $6
Feb-22-16Downgrade Citigroup Buy → Neutral
Dec-29-15Downgrade JP Morgan Overweight → Neutral $65 → $15
Dec-28-15Reiterated Piper Jaffray Overweight $63 → $10
Dec-28-15Downgrade FBR Capital Outperform → Mkt Perform $73 → $14
Dec-17-15Initiated UBS Buy $55
Oct-05-15Downgrade Morgan Stanley Overweight → Equal-Weight
Sep-03-15Initiated Citigroup Buy
Aug-18-15Initiated FBR Capital Outperform $73
Aug-06-15Reiterated Brean Capital Buy $50 → $57
May-11-15Reiterated Brean Capital Buy $45 → $50
Mar-04-15Initiated Barclays Overweight $55
Feb-12-15Reiterated Stifel Buy $47 → $57
Dec-31-14Reiterated Brean Capital Buy $33 → $45
Jul-08-14Resumed Brean Capital Buy $33
Aug-08-19 09:35AM  Chimerix (CMRX) Reports Q2 Loss, Lags Revenue Estimates Zacks
08:00AM  Chimerix Announces Second Quarter 2019 Financial Results and Operational Update GlobeNewswire
Aug-07-19 10:30AM  Chimerix (CMRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release Zacks
Aug-05-19 07:55AM  Durham pharma spends $30 million for rights to potential Leukemia treatment American City Business Journals -11.52%
Jul-31-19 07:00AM  Chimerix Announces Exclusive Worldwide License of Phase 3 Ready CX-01 for Development in Acute Myeloid Leukemia GlobeNewswire
Jul-12-19 03:07PM  Do Institutions Own Chimerix, Inc. (NASDAQ:CMRX) Shares? Simply Wall St.
Jun-28-19 06:41PM  Did Hedge Funds Drop The Ball On Chimerix Inc (CMRX) ? Insider Monkey +19.01%
May-17-19 08:18AM  Edited Transcript of CMRX earnings conference call or presentation 9-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-16-19 09:11AM  Will Chimerix to Surge Higher? Zacks
May-09-19 09:25AM  Chimerix (CMRX) Reports Q1 Loss, Tops Revenue Estimates Zacks +7.49%
08:25AM  Chimerix: 1Q Earnings Snapshot Associated Press
08:00AM  Chimerix Announces First Quarter 2019 Financial Results and Strategy Update GlobeNewswire
06:30AM  Chimerix, Inc. to Host Earnings Call ACCESSWIRE
May-02-19 04:01PM  Chimerix to Announce First Quarter 2019 Financial Results on May 9, 2019 GlobeNewswire
Apr-29-19 10:31AM  Will Chimerix (CMRX) Report Negative Q1 Earnings? What You Should Know Zacks +6.20%
Apr-12-19 01:43PM  One Thing To Remember About The Chimerix, Inc. (NASDAQ:CMRX) Share Price Simply Wall St. -7.24%
Apr-09-19 11:21AM  Chimerix taps former Endocyte executive as new CEO American City Business Journals +31.10%
08:10AM  The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing Benzinga
Apr-08-19 05:00PM  Chimerix Announces Management Updates GlobeNewswire
Apr-05-19 02:14PM  Again, Durham pharma loses a drug development partner American City Business Journals
Mar-26-19 06:30PM  Edited Transcript of CMRX earnings conference call or presentation 5-Mar-19 1:30pm GMT Thomson Reuters StreetEvents +7.43%
Mar-07-19 12:24PM  Should You Be Worried About Insider Transactions At Chimerix, Inc. (NASDAQ:CMRX)? Simply Wall St.
Mar-05-19 07:00AM  Chimerix Announces Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire -16.09%
Mar-04-19 08:00AM  Chimerix to Present at Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Feb-26-19 08:00AM  Chimerix to Announce Fourth Quarter and Full Year 2018 Financial Results on March 5, 2019 GlobeNewswire
Feb-22-19 08:00AM  Chimerix Presents Results from Post-hoc Analysis of Phase 3 Study GlobeNewswire
Feb-14-19 08:15AM  Chimerix filing reveals ex-CEO's severance package after sudden resignation American City Business Journals -7.08%
Feb-11-19 07:55AM  New Research Coverage Highlights United Parcel Service, Healthcare Trust of America, CommVault, SPX FLOW, Chimerix, and International Speedway Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Feb-06-19 02:20PM  Sudden Departure: Chimerix CEO, board member resigns American City Business Journals
08:00AM  Chimerix Announces Management Transition GlobeNewswire
Jan-30-19 11:51AM  What Type Of Shareholder Owns Chimerix, Inc.s (NASDAQ:CMRX)? Simply Wall St. +11.68%
Jan-24-19 10:17AM  Will Overall Growth Aid Thermo Fisher's (TMO) Q4 Earnings? Zacks
10:03AM  Can Solid Consumables Drive Illumina's (ILMN) Q4 Earnings? Zacks
Jan-18-19 06:36AM  What Lies Ahead for Abbott (ABT) Stock This Earnings Season? Zacks -6.57%
Jan-17-19 09:38AM  4 Medical Product Stocks Likely to Top Q4 Earnings Estimates Zacks
Jan-04-19 07:30AM  Chimerix to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire +7.14%
Dec-27-18 09:23AM  Stocks down in December for pharma firms in the Triangle American City Business Journals +6.52%
Dec-22-18 04:43AM  Should You Avoid Chimerix Inc (CMRX)? Insider Monkey
Dec-18-18 08:35AM  5 Beaten-Down Medical Product Stocks to Rebound in 2019 Zacks
Dec-12-18 11:26AM  Is Chimerix, Inc. (NASDAQ:CMRX) Overpaying Its CEO? Simply Wall St.
Dec-03-18 07:55AM  New Research: Key Drivers of Growth for Q2, BioTime, Verastem, Fair Isaac, Ulta Beauty, and Chimerix Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Nov-08-18 07:44AM  Chimerix: 3Q Earnings Snapshot Associated Press
07:00AM  Chimerix Announces Third Quarter 2018 Financial Results GlobeNewswire
Nov-07-18 08:14AM  Chimerix to Present at the Stifel 2018 Healthcare Conference GlobeNewswire
Nov-05-18 02:29PM  The most valuable public companies in the Triangle (Slideshow) American City Business Journals
Nov-01-18 08:00AM  Chimerix to Announce Third Quarter 2018 Financial Results on November 8, 2018 GlobeNewswire
Oct-27-18 01:00PM  Chimerix Presents Preclinical Data Demonstrating Antiviral Activity of Brincidofovir Against Polyomavirus at Kidney Week 2018 GlobeNewswire
Oct-24-18 07:25AM  Report: Developing Opportunities within Univar, Aqua America, Chimerix, Superior Energy Services, TechTarget, and ZIOPHARM Oncology Future Expectations, Projections Moving into 2018 GlobeNewswire -8.05%
Oct-11-18 04:01PM  Chimerix to Host Annual Investor Update on October 17, 2018 GlobeNewswire
01:23PM  How Should You Think About Chimerix Incs (NASDAQ:CMRX) Risks? Simply Wall St.
Oct-05-18 07:00AM  Chimerix Presents Results from Multiple Ascending Dose Study of IV Brincidofovir at IDWeek GlobeNewswire
Oct-04-18 07:00AM  Landmark AdVance Study Shows Adenovirus Burden Correlates with Mortality in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients GlobeNewswire
Sep-26-18 07:30AM  Chimerix to Present at Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-04-18 02:38PM  Inside The List: Highest-Paid Public Company CEOs American City Business Journals
Aug-29-18 07:00AM  Chimerix to Participate in September Investor Conferences GlobeNewswire
Aug-28-18 07:30AM  Analysis: Positioning to Benefit within MannKind, Chimerix, Superior Energy Services, Marinus Pharmaceuticals, Airgain, and Eagle Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Aug-08-18 09:50AM  Chimerix (CMRX) Reports Q2 Loss, Tops Revenue Estimates Zacks
08:43AM  Chimerix: 2Q Earnings Snapshot Associated Press
07:00AM  Chimerix Announces Second Quarter 2018 Financial Results GlobeNewswire
06:30AM  Chimerix, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-18 08:00AM  Chimerix to Announce Second Quarter 2018 Financial Results on August 8, 2018 GlobeNewswire
Jun-29-18 07:35AM  New Research: Key Drivers of Growth for Webster Financial, Chimerix, Commerce Bancshares, Teligent, Pinnacle Financial Partners, and Empire State Realty Trust Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jun-12-18 07:00AM  Chimerix Announces Discovery and Demonstrated Preclinical Activity Supporting Ongoing Phase 1 Study of New Antiviral for Treatment and Prevention of Norovirus GlobeNewswire
Jun-10-18 05:29PM  The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs Benzinga
Jun-08-18 02:17PM  What new FDA designation means for Durham's Chimerix American City Business Journals
Jun-07-18 08:41AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:30AM  Chimerix Receives Orphan Drug Designation from the FDA for Brincidofovir for the Treatment of Smallpox GlobeNewswire
Jun-05-18 05:29PM  Chimerix to Address Congressional Subcommittee in Support of Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) GlobeNewswire
May-17-18 08:20AM  Recent Analysis Shows Camden Property Trust, Biglari, Argan, Chimerix, Workhorse Group, and Magellan Midstream Partners Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
May-10-18 01:45AM  Edited Transcript of CMRX earnings conference call or presentation 7-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-07-18 10:27AM  Want To Invest In Chimerix Inc (NASDAQ:CMRX)? Heres How It Performed Lately Simply Wall St.
07:29AM  Chimerix: 1Q Earnings Snapshot Associated Press
07:00AM  Chimerix Announces First Quarter 2018 Financial Results GlobeNewswire
06:30AM  Chimerix, Inc. to Host Earnings Call ACCESSWIRE
May-02-18 08:00AM  Chimerix to Present at the Deutsche Bank 43rd Annual Health Care Conference GlobeNewswire
Apr-30-18 08:00AM  Chimerix to Announce First Quarter 2018 Financial Results on May 7, 2018 GlobeNewswire -7.47%
Apr-02-18 08:00AM  Chimerix to Present at the H.C. Wainwright Annual Global Life Sciences Conference GlobeNewswire -6.92%
Mar-30-18 03:11PM  Look what Triangle woman just became chairwoman of a $250M company American City Business Journals
Mar-29-18 04:30PM  Chimerix Announces Martha J. Demski as Board Chair; Appoints New Members to Board of Directors GlobeNewswire
Mar-23-18 08:48AM  Durham pharma pushing to fight a common cold virus that's deadly to some patients American City Business Journals
Mar-19-18 07:00AM  The AdVance Study: a Landmark Natural History Study of Adenovirus in Allogeneic Hematopoietic Cell Transplant Shows Strong Correlation Between Disease Burden and Mortality Risk GlobeNewswire
Mar-07-18 08:00AM  Chimerix to Present at Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Mar-06-18 09:47AM  Chimerix Q4 Loss Narrower Than Expected, Revenues Exceed Zacks
Mar-02-18 07:35AM  New Research: Key Drivers of Growth for Corcept Therapeutics, HubSpot, Tableau Software, Balchem, Steelcase, and Chimerix Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Mar-01-18 08:16PM  Edited Transcript of CMRX earnings conference call or presentation 1-Mar-18 1:30pm GMT Thomson Reuters StreetEvents
08:13AM  Chimerix reports 4Q loss Associated Press
07:00AM  Chimerix Announces Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
06:55AM  Chimerix, Inc. to Host Earnings Call ACCESSWIRE
Feb-22-18 08:00AM  Chimerix to Announce Fourth Quarter and Full Year 2017 Financial Results on March 1, 2018 GlobeNewswire
Feb-15-18 07:39AM  Could These 2 Biotech Stocks Really Double Your Money? Motley Fool
Jan-08-18 07:00AM  Wired News Chimerix Announced Initiation of AdAPT Study for Oral Brincidofovir and Advancement of IV Brincidofovir to Phase-2 Studies ACCESSWIRE
Jan-05-18 08:20AM  Recent Analysis Shows Chimerix, Highwoods Properties, HubSpot, Biglari, IDEXX Laboratories, and Argan Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
07:00AM  Chimerix Initiates AdAPT Study for Oral Brincidofovir and Advances IV Brincidofovir to Patient Studies GlobeNewswire
Jan-03-18 04:01PM  Chimerix to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-28-17 11:57AM  ETFs with exposure to Chimerix, Inc. : December 28, 2017 Capital Cube
Dec-27-17 08:54AM  Chimerix, Inc. :CMRX-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube
Nov-14-17 05:28AM  Edited Transcript of CMRX earnings conference call or presentation 8-Nov-17 1:30pm GMT Thomson Reuters StreetEvents
Nov-08-17 09:39AM  Should You Buy Chimerix Inc (CMRX)? Simply Wall St.
07:23AM  Chimerix reports 3Q loss Associated Press
07:00AM  Chimerix Announces Third Quarter 2017 Financial Results GlobeNewswire
Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines that address unmet medical needs in the United States. The company's lead product candidate is brincidofovir, an investigational nucleoside analog for the prevention of viral infections in hematopoietic or stem cell transplant recipients (HCT), as well as for the treatment of adenovirus infection and disease, smallpox, and BK virus infection in kidney and HCT transplant recipients. It is also developing CMX521, a nucleoside for the treatment of norovirus; and CMX157, a nucleoside analog for the treatment of HIV and hepatitis B virus infection. Chimerix, Inc. has license agreements with ContraVir Pharmaceuticals for the development and commercialization of CMX157 for various antiviral indications; Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; and Cantex Pharmaceuticals, Inc. for the development and commercialization of CX-01, a heparin derivative that is used in the treatment of acute myeloid leukemia and other serious diseases. Chimerix, Inc. was founded in 2000 and is headquartered in Durham, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DEMSKI MARTHA JDirectorMay 28Buy3.6018,00064,80037,013May 29 12:29 PM
Sherman Michael A.Chief Executive OfficerMay 20Buy3.4830,000104,31630,000May 20 04:36 PM
MIDDLETON FRED ADirectorMay 10Buy2.9230,00087,67897,523May 13 05:21 PM